Sobi Reports Change in Share and Vote Numbers
Swedish Orphan Biovitrum AB (Sobi) announced on September 30, 2026, an increase in its total number of shares and votes. The change stems from the issuance of Class C shares.
Stockholm – Swedish Orphan Biovitrum AB (Sobi) reported on September 30, 2026, an update to its total number of shares and votes. The company now has 357,636,514 shares outstanding, all of which are common shares, resulting in an equal number of votes.
The increase is attributed to the issuance of 223,677 Class C shares. These shares were issued to fulfill commitments under the long-term incentive program for permanent employees, known as the All Employee Programme. According to the conversion clause in the company's articles of association, these Class C shares have been converted into common shares.
As of September 30, 2026, Sobi holds 9,631,955 common shares in treasury. Sobi is a global biopharmaceutical company focused on rare diseases, reporting SEK 28 billion in revenue for 2025. The company's shares are listed on Nasdaq Stockholm.